Medicare Enrolled
Dr. Jayanthi Ramadurai, MD
Hematology & Oncology · Burbank, IL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Ramadurai from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ramadurai?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Ramadurai
Dr. Jayanthi Ramadurai is a hematology & oncology specialist in Burbank, IL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Ramadurai performed 160,176 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Ramadurai received a total of $15,671 from 89 pharmaceutical and/or device companies across 823 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Ramadurai is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 8% volume in IL
$15,671 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗160,176
Medicare services
Top 8% in IL for hematology & oncology
Not available
Unique patients (not deduplicated)
$15
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
28,500 | $1 | $5 |
| Oxaliplatin chemotherapy injection This procedure involves the administration of oxaliplatin, a chemotherapy medication, via injection. The dosage specified is 0.5 mg. |
21,600 | $0 | $36 |
| Pembrolizumab injection (Keytruda) | 20,600 | $43 | $146 |
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
19,050 | $0 | $6 |
| Filgrastim injection (Nivestym) for white blood cells An injection of the biosimilar medication filgrastim-aafi (Nivestym) at a dose of 1 microgram. |
17,160 | $0 | $6 |
| Nivolumab injection (Opdivo) | 14,300 | $24 | $82 |
| Daratumumab injection (Darzalex) An injection containing daratumumab and hyaluronidase-fihj administered under the skin. |
12,060 | $38 | $136 |
| Denosumab injection (Prolia/Xgeva) | 4,980 | $18 | $71 |
| Bortezomib injection, 0.1 mg Administration of a 0.1 mg dose of bortezomib medication via injection. |
3,570 | $4 | $124 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
2,001 | $98 | $400 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,924 | $0 | $2 |
| Rituximab-pvvr biosimilar injection, 10 mg An injection of rituximab-pvvr, a biosimilar medication, administered in a 10 mg dose. |
1,730 | $21 | $194 |
| Injection, leucovorin calcium, per 50 mg | 1,556 | $3 | $40 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,550 | $1 | $122 |
| Injection, fulvestrant, 25 mg | 1,320 | $8 | $262 |
| Injection, granisetron hydrochloride, 100 mcg | 980 | $0 | $25 |
| Fluorouracil injection, 500 mg Administration of a 500 mg dose of fluorouracil medication via injection. |
855 | $2 | $14 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
551 | $107 | $686 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
461 | $13 | $105 |
| Pegfilgrastim-apgf injection An injection of pegfilgrastim-apgf, a biosimilar medication. The dose specified is 0.5 mg. |
456 | $88 | $879 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
427 | $11 | $93 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
418 | $65 | $270 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
400 | $23 | $152 |
| Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | 376 | $3 | $401 |
| Magnesium sulfate injection, per 500 mg An injection of magnesium sulfate administered in 500 mg increments. |
268 | $1 | $6 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
252 | $6 | $462 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
226 | $59 | $205 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
210 | $52 | $304 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
202 | $2 | $300 |
| Pegfilgrastim injection, 0.5 mg An injection of pegfilgrastim, a medication that stimulates the production of white blood cells. This specific code applies to the brand-name drug and excludes biosimilar versions. |
192 | $88 | $1,444 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
191 | $17 | $97 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
189 | $1 | $19 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
170 | $23 | $156 |
| Anti-nausea injection (ondansetron/Zofran) | 144 | $0 | $4 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
133 | $1 | $7 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
115 | $52 | $334 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
103 | $46 | $281 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 87 | $400 | $638 |
| Nuclear medicine scan from skull base to mid-thigh with CT A nuclear medicine imaging study covering the area from the base of the skull to the middle of the thighs, performed alongside a CT scan. |
84 | $1,301 | $4,120 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
84 | $66 | $270 |
| Blood sample collection from implanted device This procedure involves drawing a blood sample directly from a medical device that has been surgically placed in the body. |
82 | $21 | $90 |
| IV chemotherapy initiation with community continuation Initiation of an intravenous chemotherapy infusion in a clinic using clinic supplies, with continuation of the infusion in a community setting such as home or assisted living. |
81 | $213 | $986 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
73 | $27 | $141 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
55 | $130 | $620 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
52 | $1 | $8 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
51 | $108 | $510 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
50 | $8 | $19 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
46 | $26 | $249 |
| Concurrent intravenous infusion Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given. |
44 | $16 | $91 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
41 | $2 | $19 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
29 | $17 | $111 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
26 | $0 | $3 |
| CT scan of chest with contrast A computed tomography scan of the chest using a contrast dye to enhance the visibility of internal structures. |
23 | $111 | $467 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
18 | $85 | $410 |
| CT scan of abdomen and pelvis with contrast A CT scan that uses dye to create detailed images of the abdomen and pelvis. This imaging test helps doctors examine internal organs and structures in these areas. |
16 | $239 | $758 |
| CT scan of chest, without contrast A computed tomography scan of the chest area that uses X-rays to create detailed images without the use of contrast dye. |
14 | $96 | $378 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
18.8% high complexity
79.4% medium
1.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$15,671
Total received (2018-2024)
Avg $2,239/year across 7 years
Top 24% in IL for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
89
Companies
823
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,713
2023
$3,298
2022
$2,563
2021
$1,572
2020
$865
2019
$1,607
2018
$2,054
Payments by company (2024)
AstraZeneca Pharmaceuticals LP
$422
Novartis Pharmaceuticals Corporation
$284
Merck Sharp & Dohme LLC
$247
Takeda Pharmaceuticals U.S.A., Inc.
$243
Gilead Sciences, Inc.
$196
Janssen Biotech, Inc.
$195
PFIZER INC.
$193
Alexion Pharmaceuticals, Inc.
$165
Eisai Inc.
$138
Lilly USA, LLC
$133
TerSera Therapeutics LLC
$101
Tempus AI, Inc
$92
GlaxoSmithKline, LLC.
$89
Regeneron Healthcare Solutions, Inc.
$81
Genmab U.S., Inc.
$75
Blueprint Medicines Corporation
$67
EMD Serono, Inc.
$67
PUMA BIOTECHNOLOGY, INC.
$65
ABBVIE INC.
$63
Kite Pharma, Inc.
$58
JAZZ PHARMACEUTICALS INC.
$58
E.R. Squibb & Sons, L.L.C.
$53
Genentech USA, Inc.
$52
Astellas Pharma US Inc
$49
BeiGene USA, Inc.
$45
Stemline Therapeutics Inc.
$43
SOBI, INC
$39
Bayer Healthcare Pharmaceuticals Inc.
$35
Incyte Corporation
$32
Daiichi Sankyo Inc.
$30
Amneal Pharmaceuticals LLC
$26
Deciphera Pharmaceuticals Inc.
$26
Sumitomo Pharma America, Inc.
$25
GENZYME CORPORATION
$25
Pharmacosmos Therapeutics Inc.
$25
Ipsen Biopharmaceuticals, Inc
$25
Blue Earth Diagnostics Limited
$23
RECORDATI_RARE_DISEASES_INC.
$22
Mirati Therapeutics, Inc.
$22
TAIHO ONCOLOGY, INC.
$21
ADC Therapeutics America, Inc.
$20
Myriad Genetic Laboratories, Inc.
$16
Agios Pharmaceuticals, Inc.
$15
Fennec Pharmaceuticals, Inc.
$15
Top 3 companies account for 25.7% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$1,077
AstraZeneca Pharmaceuticals LP
$1,066
Janssen Biotech, Inc.
$846
E.R. Squibb & Sons, L.L.C.
$734
Merck Sharp & Dohme Corporation
$721
PFIZER INC.
$719
Merck Sharp & Dohme LLC
$683
Lilly USA, LLC
$661
Amgen Inc.
$582
Genentech USA, Inc.
$392
Alexion Pharmaceuticals, Inc.
$380
Gilead Sciences, Inc.
$359
Eisai Inc.
$341
Takeda Pharmaceuticals U.S.A., Inc.
$323
Daiichi Sankyo Inc.
$319
Astellas Pharma US Inc
$297
GENZYME CORPORATION
$291
Janssen Pharmaceuticals, Inc
$257
Pharmacyclics LLC, An AbbVie Company
$256
EMD Serono, Inc.
$243
GlaxoSmithKline, LLC.
$226
Incyte Corporation
$220
TerSera Therapeutics LLC
$188
TESARO, Inc.
$179
Octapharma USA, Inc.
$177
Seagen Inc.
$174
Celgene Corporation
$173
Kite Pharma, Inc.
$165
Exelixis Inc.
$161
Blueprint Medicines Corporation
$159
G1 Therapeutics, Inc.
$145
BeiGene USA, Inc.
$143
Myriad Genetic Laboratories, Inc.
$142
Rigel Pharmaceuticals, Inc.
$135
Bayer HealthCare Pharmaceuticals Inc.
$132
Genmab U.S., Inc.
$130
ABBVIE INC.
$121
JAZZ PHARMACEUTICALS INC.
$120
Regeneron Healthcare Solutions, Inc.
$111
Karyopharm Therapeutics Inc.
$104
Tempus AI, Inc
$92
EISAI INC.
$91
Global Blood Therapeutics, Inc.
$85
ADC Therapeutics America, Inc.
$83
PUMA BIOTECHNOLOGY, INC.
$80
Bayer Healthcare Pharmaceuticals Inc.
$69
Ipsen Biopharmaceuticals, Inc
$65
Novo Nordisk Inc
$65
Stemline Therapeutics Inc.
$64
Mirati Therapeutics, Inc.
$63
Blue Earth Diagnostics Limited
$62
Pharmacosmos Therapeutics Inc.
$61
Teva Pharmaceuticals USA, Inc.
$55
Clovis Oncology, Inc.
$55
Myovant Sciences Inc.
$54
AMAG Pharmaceuticals, Inc.
$53
Taiho Oncology, Inc.
$52
Deciphera Pharmaceuticals Inc.
$50
MorphoSys, US Inc.
$46
Kyowa Kirin, Inc.
$45
Dova Pharmaceuticals
$45
Verastem, Inc.
$45
Pharmacyclics LLC, an AbbVie Company
$44
Sun Pharmaceutical Industries Inc.
$40
Puma Biotechnology, Inc.
$40
SOBI, INC
$39
Progenics Pharmaceuticals, Inc.
$36
Boehringer Ingelheim Pharmaceuticals, Inc.
$32
Amneal Pharmaceuticals LLC
$26
Sumitomo Pharma America, Inc.
$25
AbbVie, Inc.
$25
Jazz Pharmaceuticals Inc.
$24
Foundation Medicine, Inc.
$24
Helsinn Therapeutics (U.S.), Inc.
$23
GE HEALTHCARE
$22
RECORDATI_RARE_DISEASES_INC.
$22
GE HealthCare
$22
AVEO Pharmaceuticals, Inc.
$21
TAIHO ONCOLOGY, INC.
$21
Coherus Biosciences Inc.
$19
Shire North American Group Inc
$18
Epizyme, Inc.,
$17
ImmunoGen, Inc.
$16
Tactile Systems Technology Inc
$16
Agios Pharmaceuticals, Inc.
$15
Sobi, Inc
$15
Fennec Pharmaceuticals, Inc.
$15
Fresenius Kabi USA, LLC
$14
Sirtex Medical Inc
$8
Top 3 companies account for 19.1% of all-time payments
Associated products mentioned in payments ›
ADAKVEO · AFINITOR · AKYNZEO · ALUNBRIG · AVASTIN · AYVAKIT · Abraxane · Avastin · Axumin · BAVENCIO · BENDEKA · BLENREP · BOSULIF · BRUKINSA · Balversa · Bavencio · Blincyto · CABOMETYX · CALQUENCE · CARVYKTI · CHANTIX · COSELA · CYRAMZA · Cabometyx · Columvi · Copiktra · DARZALEX · DOPTELET · Doptelet · ELIQUIS · ELITEK · ELZONRIS · EMPLICITI · ENHERTU · ENJAYMO · EPKINLY · ERBITUX · ERLEADA · Elahere · Enhertu · Epkinly · Erleada · FARESTON · FERAHEME · FLEXITOUCH · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Fabhalta · GAZYVA · GILOTRIF · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INREBIC · Imbruvica · Itovebi · JADENU · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LIBTAYO CEMIPLIMAB-RWLC INJECTION · LONSURF · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lunsumio · MEKINIST · MONJUVI · MONOFERRIC · MVASI · MYRISK · NERLYNX · NINLARO · Neulasta · Novoeight · Nplate · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Onivyde · Orserdu · PADCEV · PIQRAY · PLUVICTO · POSLUMA · POTELIGEO · PROMACTA · PYLARIFY · Padcev · Pedmark · Perjeta · Pomalyst · QINLOCK · REBLOZYL · RETEVMO · RYBREVANT · Revlimid · Rezlidhia · Rubraca · SANCUSO · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · SOLIRIS · SUTENT · SYLVANT · Somatuline Depot · Stimufend · Stivarga · TABRECTA · TAGRISSO · TALZENNA · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TUKYSA · Tavalisse · Tazverik · Trodelvy · ULTOMIRIS · Udenyca · Ultomiris · VENCLEXTA · VERZENIO · VONJO · VPRIV · VYXEOS · Venclexta · XALKORI · XARELTO · XGEVA · XPOVIO · XTANDI · Xermelo · Xofigo · Xospata · YONSA · Yescarta · ZEJULA · ZEPZELCA · ZOLADEX · Zoladex · myRisk
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
355
County median income
$81,797
Nearest hospital to ZIP centroid (approximate)
ADVOCATE CHRIST HOSPITAL & MEDICAL CENTER
2.2 mi
2.2 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Ramadurai is a mixed practice specialist, with above-average Medicare volume (top 8% in IL), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Ramadurai experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Ramadurai performed 28,500 iron infusion (injectafer) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Ramadurai receive payments from pharmaceutical companies?
Yes. Dr. Ramadurai received a total of $15,671 from 89 companies across 823 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ramadurai's costs compare to other hematology & oncology specialists in Burbank?
Dr. Ramadurai's average Medicare payment per service is $15. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ramadurai) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Burbank
Browse hematology & oncology specialists in Burbank ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in IL
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in IL
Which IL hematology & oncology specialists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology